Blogs

Aug 07, 2017
Applied Clinical Trials
The release of the ICH E6 R2 guidance, which outlines a new approach to clinical trials operations, will have a major impact on the industry, writes Patrick Hughes.
Aug 04, 2017
Applied Clinical Trials
In this interview, we speak to Dr. Joanne Waldstreicher, Chief Medical Officer of J&J’s Office of the Chief Medical Officer (OCMO), to discuss its data sharing program via the Yale University Open Data Access (YODA) Project.
Aug 02, 2017
Applied Clinical Trials
How can manufacturers ensure their clinical trial methods are evolving along with their product portfolio? It starts by taking a patient-focused approach to trial design, writes Susan Weidner.
Aug 02, 2017
Applied Clinical Trials
Of the 28 European Union member states, nine did not make an offer to host the European Medicines Agency (EMA) by the July 31 deadline—and one of them is very sorely missed, writes Peter O'Donnell.
Jul 27, 2017
Applied Clinical Trials
With the rise in deaths, injuries, and treatment costs related to the abuse and misuse of opioid painkillers, the biomedical research community is seeking more effective and informative methods for testing and evaluating new pain medicines. Jill Wechsler reports.
Jul 26, 2017
Applied Clinical Trials
Jill Wechsler discusses the importance of clinical trial participants and the challenges FDA faces in expanding patient engagement.
Jul 17, 2017
Applied Clinical Trials
Peter O'Donnell discusses Brexit challenges and how the life sciences industry is affected.
Jul 14, 2017
Applied Clinical Trials
In this article, MedCision executive discusses cell therapies.
Jul 13, 2017
Applied Clinical Trials
This Q&A discusses how the movement in making studies more patient-centric continues, and Pfizer is now implementing its own mHealth study in Lupus.
Jul 06, 2017
Applied Clinical Trials
Peter O'Donnell discusses the interest expressed by members states to host the EMA.
native1_300x100
lorem ipsum